Last reviewed · How we verify
Liquifilm artificial tears eyedrops
Liquifilm artificial tears eyedrops is a Artificial tear lubricant Small molecule drug developed by Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA. It is currently in Phase 3 development for Dry eye disease, Ocular surface lubrication and protection. Also known as: Artificial tears.
Liquifilm artificial tears provide lubrication and moisture to the ocular surface by supplementing natural tear film.
Liquifilm artificial tears provide lubrication and moisture to the ocular surface by supplementing natural tear film. Used for Dry eye disease, Ocular surface lubrication and protection.
At a glance
| Generic name | Liquifilm artificial tears eyedrops |
|---|---|
| Also known as | Artificial tears |
| Sponsor | Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA |
| Drug class | Artificial tear lubricant |
| Modality | Small molecule |
| Therapeutic area | Ophthalmology |
| Phase | Phase 3 |
Mechanism of action
Artificial tears are topical ophthalmic solutions designed to mimic the composition and function of natural tears, providing lubrication, hydration, and protection to the cornea and conjunctiva. They help reduce friction between the eyelid and eye surface, alleviate discomfort, and maintain corneal clarity in patients with dry eye disease or tear deficiency.
Approved indications
- Dry eye disease
- Ocular surface lubrication and protection
Common side effects
- Transient blurred vision
- Eye irritation
- Ocular discomfort
Key clinical trials
- Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca) (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Liquifilm artificial tears eyedrops CI brief — competitive landscape report
- Liquifilm artificial tears eyedrops updates RSS · CI watch RSS
- Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA portfolio CI
Frequently asked questions about Liquifilm artificial tears eyedrops
What is Liquifilm artificial tears eyedrops?
How does Liquifilm artificial tears eyedrops work?
What is Liquifilm artificial tears eyedrops used for?
Who makes Liquifilm artificial tears eyedrops?
Is Liquifilm artificial tears eyedrops also known as anything else?
What drug class is Liquifilm artificial tears eyedrops in?
What development phase is Liquifilm artificial tears eyedrops in?
What are the side effects of Liquifilm artificial tears eyedrops?
Related
- Drug class: All Artificial tear lubricant drugs
- Manufacturer: Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA — full pipeline
- Therapeutic area: All drugs in Ophthalmology
- Indication: Drugs for Dry eye disease
- Indication: Drugs for Ocular surface lubrication and protection
- Also known as: Artificial tears
- Compare: Liquifilm artificial tears eyedrops vs similar drugs
- Pricing: Liquifilm artificial tears eyedrops cost, discount & access